Medicinal Marijuana Association

FEBRUARY 10, 2024

Implement research findings by consulting experts and translating data into practical actions. Research methodologies in cannabis studies can vary from observational studies that simply observe and report data, to randomized controlled trials that provide more robust evidence.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

The Joint Blog

DECEMBER 9, 2019

The twice-daily administration of plant-derived CBD-dominant extracts is associated with symptom improvement in adolescents with autism spectrum disorder (ASD), according to observational data published in the journal Frontiers in Neurology.

CBD 49

CBD Extraction Epilepsy Sativa 49

Canna Law Blog

NOVEMBER 29, 2019

Epidiolex is used to treat epilepsy and requires a prescription. The FDA didn’t frame the issue of Hemp-CBD interactions as something to be aware of or something to watch out for; it was presented as a way that Hemp-CBD can hurt consumers. The fact is that the interest in CBD has eclipsed the scientific data we have available.

Hemp 139

Hemp CBD Data Food 139

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Shutterstock). One of the leading cannabis clinicians in the U.S.,

CBD 122

CBD Research and Development Epilepsy Extraction 122

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Cannabis Law Report

JULY 25, 2022

Although a lot of research is being conducted on the subject, no conclusive medical data has been provided to the medical community. Some of the most common findings were that patients experienced relief with conditions and symptoms such as inflammation, severe nausea, insomnia, loss of appetite, muscle spasms, epilepsy, and many more.

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

The Cannigma

OCTOBER 21, 2021

As per usual, more data is needed. Epilepsy is the most obvious example, where the ketogenic diet has been applied for 100 years, cannabis has long been treated as is now also an FDA-approved treatment for a number of seizure disorders. The keto-canna connection: what do keto and cannabis have in common?

Cannabinoids 143

Cannabinoids Edibles Conditions Data 143

Cannabis Law Report

AUGUST 5, 2019

French patients who suffer from pain not treated by other medicines will be eligible, and the committee is looking for anyone in palliative care, epilepsy patients, and those suffering from the side effects of chemotherapy. Patients with muscle spasms related to multiple sclerosis are also invited to take part.

Medicine 60

Medicine Patients Digestion Epilepsy 60

Canna Law Blog

DECEMBER 16, 2021

Data from the RAND Corporation show that 8,000 New York veterans from the Wars in Iraq and Afghanistan suffer from PTSD. The FDA recognizes psilocybin therapy as substantially better than present treatment options.

Legislation 97

Legislation Treatment Therapy Conditions 97

CannaTech

SEPTEMBER 16, 2018

Similar frameworks exist across the world, presenting the same set of challenges Canada has faced along the way. But this gap restricts patient access to a medicine that can offer relief to a long list of conditions including chronic pain, seizures attributed to epilepsy, as well as mood disorders such as anxiety and depression.

Education 66

Education Medicine Clinical Trials Patients 66

The Joint Blog

JANUARY 23, 2020

. “Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and vomiting, and intractable childhood epilepsy. Yet its potential application in the field of psychiatry is lesser known.”

Clinical Trials 52

Clinical Trials Sleep Marijuana Cannabinoids 52

Leaf Science

JULY 23, 2019

In spite of this, research has shown that THC as much as the other cannabinoids present in cannabis has medicinal value to humans. In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74

Strains Cannabinoids Epilepsy THC 74

Veriheal

AUGUST 31, 2020

It brings us great pleasure to present the 10 winners of Veriheal’s Innovation in Cannabis Scholarship 2020. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. School: Tufts University.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Chronicles

FEBRUARY 15, 2019

Fairwinds employs more than 20 people, and Hull pointed to sales data showing their products were among the top sellers in Washington’s legal cannabis market last quarter, with over $4 million in retail sales. There are a lot of claims in the (cannabis) industry about what a product does: ‘This cures pain or epilepsy,’ ” Smith said.

Packaging 100

Packaging Sleep Legislation Policy 100

Cannabis Law Report

JANUARY 13, 2020

Justin Gover, GW’s Chief Executive Officer expects to discuss these updates as part of a webcast presentation at the 38 th Annual J.P. Continue to explore CBDV in autism through a combination of open-label and investigator-led placebo controlled clinical trials with data from one or more of these programs in 2020. 14th at 11:00 a.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

The Joint Blog

AUGUST 7, 2020

The cannabinoid CB1 is present in the brain in larger concentration, although it is present throughout the body. These include epilepsy, Dravet’s syndrome, autism, anxiety and more. In fact, with kids who have epilepsy and Dravets syndrome, some observe that the intake of CBD drastically reduces the occurrence of seizures.

CBD 26

CBD Oil Digestion Edibles 26

The Joint Blog

JULY 14, 2021

There has been inadequate research conducted and not enough data that fully supports the use of CBD for the elderly. Older people with underlying conditions such as kidney disease, liver disease, epilepsy, weak immune system, and heart issues should mention it to the doctor before using CBD. The dangers of CBD Products to the Elderly.

Medicine 52

Medicine CBD Chronic Pain Blood Pressure 52

Greencamp

AUGUST 16, 2018

The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Exploring the available research on ALS and cannabinoids.

Strains 94

Strains Cannabinoids Research and Development Indica 94

CannaMD

AUGUST 19, 2020

While future research is needed, the present study opens up a new landscape for marijuana research – focusing on terpenes just as much as cannabinoids. Our initial data suggest that some C. Could Marijuana Prevent COVID-19?

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

Cannabis Law Report

JANUARY 27, 2020

It’s always been present in hemp oils and seed derived products, albeit in low concentrations. The US Food and Drug Administration (FDA) asserts its case clearly on its website, emphasising that it has approved only one product, and that’s a prescription drug to treat two rare forms of epilepsy. Alarm 2: EFSA, EU.

Safety 59

Safety CBD Food Seed-To-Sale 59

Cannabis Law Report

OCTOBER 26, 2021

President, Director and Chief Medical Officer of MyMD, will be honored by the Arthritis Foundation as its Medical Honoree of 2021, to be presented at the annual Commitment to a Cure Gala being held October 28, 2021, in Washington, D.C. “I 1 Data published by Research and Markets, March 2018. MyMD: Robert Schatz. 646) 421-9523.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

OCTOBER 1, 2021

Mack will present an overview of Virpax and take part in a fireside chat moderated by Noble Capital Markets senior equity research analyst, Gregory Aurand at the Pain Management Virtual Investor Forum on Thursday, October 7, 2021 at 9:00 a.m. Eastern time. www.youtube.com/channelchek. About Virpax Pharmaceuticals. About Channelchek.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Chronic Pain 52

Cannabis Law Report

FEBRUARY 17, 2020

” These necessary individuals present the finished state-certified cannabis product on the dispensary’s shelves in an appealing manner. Renewals must be submitted at least forty-five (45) days prior to the present card expiration date; a complete renewal application, $75 and required documentation must be submitted to the state.

Dispensary 76

Dispensary Patients Agriculture Conditions 76

Cannabis Law Report

JANUARY 20, 2022

Investor Presentation Information. Eleusis and Silver Spike have prepared a prerecorded investor presentation. The investor presentation will also be furnished today to the SEC, which can be viewed at the SEC’s website at www.sec.gov. II, and Davis Polk & Wardwell LLP is serving as its legal advisor.

Therapy 52

Therapy Research and Development Business Access 52

Ellementa

NOVEMBER 4, 2019

CBD research shows it can be effective in treating severe forms of epilepsy such as Dravet syndrome and Lennox-Gastaut syndrome (LGS). Ellementa and TruPotency Present a special webinar on Wednesday, Nov. Our Presenting Sponsor is TruPotency. CBD as an anti-seizure medication is affecting the mind.

CBD 14

CBD Tincture Blood Pressure THC 14

Cannabis Law Report

SEPTEMBER 12, 2021

She sought to make sense of the issues during her presentation “Medical Cannabinoids Revisited” at AVMA Virtual Convention 2021 on Aug. For several millennia, humans have used cannabinoids for pain, epilepsy, gastrointestinal disorders, and even infections. Cats are more challenging. I am excited about CBD,” she said. “I

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

The Cannigma

JUNE 29, 2021

Sometimes the next-most abundant compounds can present a rich variability or even be more chemically active. It’s also the most appropriate for medical conditions such as depression , epilepsy , and autism spectrum disorder. Type III is good for consumers with low tolerance to THC, or for new users looking to gauge their tolerance.

Terpenes 138

Terpenes Research and Development Cannabinoids Concentrates 138

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Data collection. Palliative care indications.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

MAY 17, 2019

Because it can’t be sold between the states and is presently incapable of entering the stream of interstate commerce, the Marijuana industry has been spared the FDA’s scrutiny. Third, what does this portend for cannabis?

Food 10

Food DEA Hemp CBD 10

Cannabis Law Report

NOVEMBER 15, 2021

Finally, we recently acquired the worldwide rights to VRP324, which is an intranasal pharmaceutical-grade cannabidiol product candidate for the management of epilepsy in children (rare pediatric disease) and adults. VRP324 represents our first CNS disorder product indication. On September 9, 2021, Jeffrey A. Forward-Looking Statement.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Healer

JANUARY 17, 2022

While THC’s maximal pain reduction was better (THC had the potential for stronger relief at much higher doses), this data suggests CBG could be a cost-effective agent for pain, effective at low doses without the impairment possibility related to THC. CBGA in a mouse model of epilepsy. CBG was effective at 1.26

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

Healer

JANUARY 17, 2022

While THC’s maximal pain reduction was better (THC had the potential for stronger relief at much higher doses), this data suggests CBG could be a cost-effective agent for pain, effective at low doses without the impairment possibility related to THC. CBGA in a mouse model of epilepsy. CBG was effective at 1.26

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

The Joint Blog

NOVEMBER 30, 2021

Neither product will get you high, but it’s important to note that THC is present. The rise of CBD has increased the focus and funding of these trials and the expectation is for more data in the coming years. . Depending on your line of work and company’s policies, it is worth noting. Benefits of CBD Oil. Chronic pain. Depression.

Oil 26

Oil CBD Vaping Digestion 26

SMPL

MAY 26, 2020

Within a couple of years, they figured out a 1:1 combination of a high-THC chemovar and a high-CBD chemovar presented the greatest latitude of effects and prevention of side effects,” said Dr. Ethan Russo, who worked with GW Pharmaceuticals from 1998 to 2014. Watson and Mr. Clarke’s collection of cannabis and got to work.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Green Relief

MAY 13, 2018

It is the most commonly identified cause of epilepsy among adults. CB2 receptors are present in progenitor (“stem”) cells and are instrumental in driving neurogenesis (the creation of new brain cells). Preliminary data suggests that a synergistic combination of CBD and hypothermia may produce the best results. CBD for CTE.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

It is the most commonly identified cause of epilepsy among adults. CB2 receptors are present in progenitor (“stem”) cells and are instrumental in driving neurogenesis (the creation of new brain cells). Preliminary data suggests that a synergistic combination of CBD and hypothermia may produce the best results. CBD for CTE.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. It seems as though research on cannabis and cannabinoids is taking such large strides that it even surpasses research growth in other fields.

Medicine 81

Medicine Research and Development Data Policy 81